| Security Name | Ticker | % of Net Assets |
|---|---|---|
| ABBVIE INC | ABBV | 8.06% |
| AMGEN INC | AMGN | 5.83% |
| GILEAD SCIENCES INC | GILD | 5.14% |
| VERTEX PHARMACEUTICALS INC | VRTX | 4.30% |
| MODERNA INC | MRNA | 4.11% |
| REGENERON PHARMACEUTICALS INC | REGN | 3.86% |
| BEONE MEDICINES LTD | ONC | 2.67% |
| ROYALTY PHARMA PLC | RPRX | 2.38% |
| NATERA INC | NTRA | 2.37% |
| BIOGEN INC | BIIB | 2.32% |
| ILLUMINA INC | ILMN | 2.06% |
| REVOLUTION MEDICINES INC | RVMD | 2.04% |
| VIATRIS INC | VTRS | 1.99% |
| UNITED THERAPEUTICS CORP | UTHR | 1.93% |
| INSMED INC | INSM | 1.78% |
| ROIVANT SCIENCES LTD | ROIV | 1.70% |
| INCYTE CORP | INCY | 1.63% |
| EXELIXIS INC | EXEL | 1.62% |
| GUARDANT HEALTH INC | GH | 1.58% |
| NEUROCRINE BIOSCIENCES INC | NBIX | 1.55% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | 1.55% |
| ASTRAZENECA PLC | AZN | 1.55% |
| BRIDGEBIO PHARMA INC | BBIO | 1.43% |
| ARGENX SE | ARGX | 1.40% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 1.34% |
| ALKERMES PLC | ALKS | 1.29% |
| VAXCYTE INC | PCVX | 1.22% |
| TG THERAPEUTICS INC | TGTX | 1.18% |
| HALOZYME THERAPEUTICS INC | HALO | 1.17% |
| SPYRE THERAPEUTICS INC | SYRE | 1.16% |
| BIOMARIN PHARMACEUTICAL INC | BMRN | 1.12% |
| MEDPACE HOLDINGS INC | MEDP | 1.04% |
| BIONTECH SE | BNTX | 1.04% |
| ASCENDIS PHARMA A/S | ASND | 0.98% |
| CRISPR THERAPEUTICS AG | CRSP | 0.96% |
| KYMERA THERAPEUTICS INC | KYMR | 0.91% |
| CYTOKINETICS INC | CYTK | 0.90% |
| GRAIL INC | GRAL | 0.82% |
| PTC THERAPEUTICS INC | PTCT | 0.80% |
| PROTAGONIST THERAPEUTICS INC | PTGX | 0.78% |
| TWIST BIOSCIENCE CORP | TWST | 0.76% |
| ORUKA THERAPEUTICS INC | ORKA | 0.76% |
| KRYSTAL BIOTECH INC | KRYS | 0.75% |
| COGENT BIOSCIENCES INC | COGT | 0.74% |
| AXSOME THERAPEUTICS INC | AXSM | 0.72% |
| MADRIGAL PHARMACEUTICALS INC | MDGL | 0.71% |
| ARROWHEAD PHARMACEUTICALS INC | ARWR | 0.71% |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.71% |
| SCHOLAR ROCK HOLDING CORP | SRRK | 0.70% |
| ADMA BIOLOGICS INC | ADMA | 0.70% |
| RHYTHM PHARMACEUTICALS INC | RYTM | 0.69% |
| TRAVERE THERAPEUTICS INC | TVTX | 0.68% |
| CG ONCOLOGY INC | CGON | 0.67% |
| MIRUM PHARMACEUTICALS INC | MIRM | 0.64% |
| LIQUIDIA CORP | LQDA | 0.64% |
| BEAM THERAPEUTICS INC | BEAM | 0.60% |
| VIKING THERAPEUTICS INC | VKTX | 0.60% |
| SUMMIT THERAPEUTICS INC | SMMT | 0.57% |
| IMMUNITYBIO INC | IBRX | 0.55% |
| IONIS PHARMACEUTICALS INC | IONS | 0.55% |
| PRAXIS PRECISION MEDICINES INC | PRAX | 0.53% |
| RECURSION PHARMACEUTICALS INC | RXRX | 0.52% |
| ULTRAGENYX PHARMACEUTICAL INC | RARE | 0.48% |
| LEGEND BIOTECH CORP | LEGN | 0.46% |
| ACADIA PHARMACEUTICALS INC | ACAD | 0.45% |
| INTELLIA THERAPEUTICS INC | NTLA | 0.45% |
| SAREPTA THERAPEUTICS INC | SRPT | 0.43% |
| CELCUITY INC | CELC | 0.42% |
| VERACYTE INC | VCYT | 0.39% |
| DIANTHUS THERAPEUTICS INC | DNTH | 0.38% |
| AKERO THERAPEUTICS INC | AKRO | 0.00% |
| Other (Cash, derivatives and other liabilities) | 0.48% | |
| Total: | ||
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.